The glycine and 5-hydroxytryptamine type 3 (5-HT 3 ) receptors are the superfamily of ligand-gated ion channel receptors with cysteine loop and share a structural similarity with nicotinic acetylcholine and g-aminobutyric acid A (GABA A ) receptors.
Differential Regulations of Quercetin and Its Glycosides on Ligand-Gated Ion Channels

10)
Oocyte Preparation Xenopus laevis frogs were purchased from Xenopus I (Ann Arbor, MI, U.S.A.). Xenopus laevis care and handling were in accordance with the guide for the Care and Use of Laboratory Animals published by NIH, U.S.A. Frogs underwent surgery only twice, separated by at least 3 weeks. To isolate oocytes, frogs were anesthetized with an aerated solution of 3-amino benzoic acid ethyl ester. Oocytes were separated by treatment with collagenase, by gentle shaking for 2 h in CaCl 2 -free medium containing 82.5 mM, NaCl, 2 mM KCl, 1 mM MgCl 2 , 5 mM HEPES, 2.5 mM sodium pyruvate, 100 units penicillin/ml, and 100 mg streptomycin/ml. Only stage 5 or 6 oocytes were collected and maintained at 18°C with continuous gentle shaking in ND96 (96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , and 5 mM HEPES, pH 7.5) supplemented with 0.5 mM theophylline and 50 mg gentamycin/ml. All solutions were changed every day. All experiments were performed within 2-4 d following isolation of the oocytes.
Oocyte Recording A single oocyte was placed in a small Plexiglas net chamber (0.5 ml) and was constantly superfused with ND96 medium (96 mM NaCl, 2 mM KCl, 1 mM MgCl 2 , 1.8 mM CaCl 2 , and 5 mM HEPES, pH 7.5). The microelectrodes were filled with 3 M KCl and had a resistance of 0.2-0.7 MW. Two-electrode voltage-clamp recordings were performed at room temperature with Oocyte Clamp (OC-725C, Warner Instrument, Hamden, CT, U.S.A.) with Digidata 1200A (Axon Instruments, Union City, CA, U.S.A.). For most of the electrophysiological experiments, the oocytes were clamped at a holding potential of Ϫ80 mV and 300-ms voltage steps for current-voltage relationship were applied from Ϫ100 to ϩ40 mV and ϩ60 mV for glycine a1 receptor and 5-HT 3A receptor, respectively. 6, 7) cRNA Preparation of the Glycine a a1 or 5-HT 3A Receptor and Microinjection The cDNAs encoding the human glycine a1 receptor and mouse 5-HT 3A . receptor was linearized by digestion with appropriate restriction enzymes. The cRNAs were transcribed from linearized templates with in vitro transcription kit (mMessage mMachine; Ambion, Austin, TX, U.S.A.) using a T3 polymerase. The cRNA was dissolved in RNase-free water at a final concentration of approximately 1 mg/ml and stored at Ϫ70°C until used. Oocytes were injected with H 2 O, human glycine receptor, or mouse 5-HT 3A . receptor cRNAs (5-10 ng) by using a Nanoject Automatic Oocyte Injector (Drummond Scientific, Broomall, PA, U.S.A.). The injection pipette was pulled from glass capillary tubing used for recording electrodes and the tip was broken to ca. 20-mm-OD.
Data Analysis To obtain the concentration-response curve for glycine or 5-HT-induced current in the presence of quercetin or its glycosides, the observed peak amplitudes were normalized and plotted and then fitted to the Hill equation below using Origin software (Northampton, MA,
, where y, % inhibition at given concentration of quercetin or its glycosides, y max , % of maximal inhibition, IC 50 is the concentration of quercetin producing half-maximum inhibition of the control response to glycine or 5-HT, and [A] is the concentration of quercetin or its glycosides. n is the interaction coefficient. All values are presented as meansϮS.E.M. The differences between means of control and quercetin or its glycosides treatment data were analyzed using unpaired Student's t test and oneway ANOVA with post-hoc Tukey test. A value of pϽ0.05 was considered statistically significant.
RESULTS
Effects of Quercetin and Its Glycosides on Human
Glycine a a1 and Mouse 5-HT 3A Receptor-Mediated Currents As previous reports, we could observe that application of glycine (100 mM) or 5-HT (1 mM) to bathing medium induced a large inward current (I Gly or I 5-HT ) in oocytes injected with cRNAs coding glycine or 5-HT 3A receptor (Fig.  2) . Strychnine (0.5 mM) and MDL72222 (0.5 mM), of which the respective glycine receptor and 5-HT 3A receptor antagonist blocked I Gly and I 5-HT (data not shown), indicating that the glycine and 5-HT 3A receptor were functionally expressed in this system as previous reports. 6, 7) In the present study, we examined the effects of quercetin glycosides on I Gly or I 5-HT . Quercetin and its glycosides (each 100 mM) themselves had no effect in oocytes expressing the glycine or 5-HT 3A receptor at a holding potential of Ϫ80 mV. However, co-application of quercetin (Que) or its glycosides with glycine or 5-HT inhibited I Gly or I 5-HT in a reversible manner ( Fig. 2A , nϭ15 from three different frogs) (Figs. 2A, B ( Fig. 2C) . Thus, the inhibitory potency for I Gly was in order of quercetinϾRutinՆRham1ϾRham2 and the inhibitory potency for I 5-HT was in order of Rham2ՆquercetinϾRutinϭ Rham1. Glycosylations of quercetin affect on glycine but not 5-HT 3A receptor channel current inhibitions. In addition, since quercetin more strongly inhibited I 5-HT or I Gly than other quercetin glycosides tested, we tested using quercetin whether pre-application of quercetin caused further inhibition on I 5-HT or I Gly compared to its co-application with glycine or 5-HT. As shown in Figs. 3A and B, pre-application of quercetin did not induce further inhibition of I 5-HT or I Gly compared to co-application of quercetin with glycine or 5-HT. Thus, the percent inhibitions in co-application of quercetin were 52.3Ϯ6.4% for I Gly and 49.5Ϯ5.0% for I 5-HT . The percent inhibitions in pre-application of quercetin were 54.3Ϯ3.4% for I Gly and 52.1Ϯ3.4% for I (Fig. 3C) , indicating that either co-or pre-application causes the same extent of inhibitions on I 5-HT and I Gly . Table 1 ). The IC 50 values of qeurcetin glycosides on glycine receptor were significantly higher than that of quercetin. Especially, it appears that the increase in IC 50 value was related with number of quercetin glycosidation. Finally, quercetin's glycosylation caused dose-response curves to rightward shift. These results show a possibility that quercetin rather than quercetin glycosides is the main regulator of glycine receptor channel activity. In 5-HT 3A receptors, the IC 50 values were not significantly changed between quercetin and its glycosides, except for Rham1 (Fig. 4 , Table 1 ), indicating that glycosylations of quercetin did not much affect on 5-HT 3A receptor channel regulations.
Concentration-Dependent Effect of Quercetin and Its Glycosides on I
Quercetin Glycosides Inhibit I Gly with Non-competitive, Whereas They Inhibit I 5-HT with Competitive Manner To study further the mechanism by which quercetin and its glycosides inhibit I Gly and I 5-HT , we first analyzed the effects of quercetin and its glycosides on I Gly evoked by different glycine concentrations in oocytes expressing the glycine receptors (Fig. 5A ). Co-application of quercetin or its glycosides for 30 s with different concentrations of glycine did not significantly shift the dose-response curve of glycine. The EC 50 values were 168.9Ϯ0.9, 167.4Ϯ2.0, 173.9Ϯ0. 3, 193 .5Ϯ0.1 and 156.5Ϯ0.4 mM for glycine alone, glycineϩ quercetin, glycineϩRham1, glycineϩRutin, and glycineϩ Rham2, respectively and the Hill coefficients were 2.6, 3.4, 2.9, 2.5 and 2.8, respectively. Thus, quercetin, Rham1, Rutin, and Rham2 significantly inhibited the I Gly elicited by 100, 300 and 1000 mM of glycine, which are independent on the glycine concentrations (nϭ9-12 from three different frogs) (Fig. 5A, Table 2 ). These results indicate that quercetin and its glycosides inhibit the I Gly in a non-competitive manner.
Next, we also analyzed the effects of quercetin and its gly- I Gly in oocytes expressing the glycine receptor was measured with the indicated concentration of glycine alone (ᮀ) and glycine ϩ25 mM quercetin (᭺), ϩ60 mM Rham1 (᭝), ϩ65 mM Rutin (᭞) and ϩ100 mM Rham2 (᭛). Oocytes were voltage-clamped at a holding potential of Ϫ80 mV. Oocytes were exposed to glycine alone or glycineϩquercetin, ϩRham1, ϩRutin andϩRham2 treatment for 30 s. 0.005, compared with 5-HT alone) and the Hill coefficients were 1.9, 1.6, 1.5, 1.9 and 1.8, respectively (Table 2) . Thus, these results indicate that quercetin and its glycosides inhibit the I 5-HT in a competitive manner. Altogether, these results indicate that quercetin and its glycosides regulate glycine and 5-HT 3A receptor channel activities with differential manners.
(B) Dose-Response Relationship for 5-HT and 5-HTϩQuercetin and Its Glycosides in Oocytes Expressing the Mouse 5-HT Receptor
Current-Voltage Relationships in Quercetin and Its Glycosides-Mediated Human Glycine a a1 and 5-HT 3A Receptor Regulations In experiments of the current-voltage relationship, the membrane potential was held at Ϫ80 mV and a voltage ramps for 300 ms were applied from Ϫ100 to ϩ40 mV for glycine receptor. In the absence of glycine, the inward current at Ϫ100 mV was Ͻ0.1 mA and the outward current at ϩ40 mV was 0.1-0.4 mA in the glycine receptor (Fig. 6A) . The addition of glycine to the bathing medium resulted in an increase of the inward current at a potential more negative than approximately Ϫ20 mV. In contrast, at a potential more positive than approximately Ϫ20 mV, glycine led to a large increase in outward current. Co-application of quercetin and its glycosides with glycine inhibited both the inward and outward currents more than those induced by glycine treatment alone. The reversal potential was also near Ϫ20 mV in both glycine alone and glycineϩquercetin and its glycosides. The inhibitory effects of quercetin and its glycosides on I Gly in oocytes expressing the glycine receptor were voltage-sensitive (Fig. 6A) In experiments of the current-voltage relationship using 5-HT 3A receptors, the membrane potential was also held at Ϫ80 mV and a voltage ramps for 300 ms were applied from Ϫ100 to ϩ60 mV for 5-HT 3A receptors, respectively. In the absence of 5-HT, the inward current at Ϫ100 mV was Ͻ0.1 mA and the outward current at ϩ60 mV was 0.1 mA in the 5-HT 3A receptor (Fig. 6B) . The addition of 5-HT to the bathing medium resulted in an increase of the inward current at negative voltages, and an outward current at positive voltages. The reversal potential was near 0 mV with 5-HT alone as well as 5-HTϩquercetin and its glycosides. Co-application of quercetin and its glycosides with 5-HT inhibited both the inward and outward currents more than those induced by 5-HT treatment alone. The inhibitory effects of quercetin and its glycosides on I 5-HT in oocytes expressing 5-HT 3A receptor were voltage-insensitive (Fig. 6B) . Thus, quercetin, Rham1, Rutin and Rham2 inhibited I 5-HT by 43.1Ϯ2.4%, 40.1Ϯ2.2%, 33.0Ϯ3.0 and 50.7Ϯ2.7% at Ϫ100 mV, respectively; and by 45.8Ϯ3.0%, 44.1Ϯ2.0%, 32.9Ϯ3.7 and 54.2Ϯ2.1% at ϩ60 mV, respectively (nϭ10-12, from three different frogs). These results indicate that quercetin inhibits I Gly in a voltageinsensitive manner.
DISCUSSION
Quercetin, one of the flavonoids, and its glycosides are substances of low molecular weight mainly found in apple, tomato, gingko and other red fruits (Fig. 1A) . 12) Quercetin shows a wide range of biological activities, [13] [14] [15] with neuropharmacological actions such as analgesia, motility and sleep, 16, 17) neuronal oxidative modulations, 18) proconvulsant, anticonvulsant, sedative and anxiolytic effects. [19] [20] [21] The cellular mechanisms underlying quercetin, especially on synaptic transmissions are not well studied. In the previous studies, we could demonstrate that quercetin regulates glycine and 5-HT 3A receptor channel activities. 6, 7) However, although most of quercetin in fruits and vegetables exist as quercetin glycosides, the pharmacological and physiological roles of those quercetin glycosides are relatively unknown in nervous systems.
In the present study, we demonstrated that (1) quercetin was more potent for the inhibition of I Gly than other quercetin glycosides, whereas quercetin and its glycosides except Rham1 and rutin were equally potent for the inhibition of I 5-HT ; (2) quercetin glycosides inhibited both I Gly and I 5-HT in a concentration-dependent and reversible manner in oocytes expressing the human glycine a1 or mouse 5-HT 3A receptors; (3) quercetin glycosides-induced inhibitions of I Gly were non-competitive and voltage-sensitive, whereas quercetin glycosides-induced inhibitions of I 5-HT were competitive and voltage-insensitive, indicating that quercetin glycosides regulate glycine and 5-HT 3A receptor with differential manners.
It has been known that dietary quercetin and its glycosides are metabolized into three ways. First is to remain in intact quercetin or conjugated with glucoses or sulfates to produce quercetin glucuronides or quercetin sulfates in blood stream; second way is to deglycosylate quercetin to quercetin aglycone; third way is to remain with quercetin glycosides without further metabolisms. 8, 9) Interestingly, quercetin glucuronides or quercetin sulfates maintain their biological activities as antioxidants if they are conjugated with carbon-3 but not carbon-4. These results indicate that the antioxidant effects of quercetin and its metabolites are due to catechol A) The representative current-voltage relationship was obtained using voltage ramps from Ϫ100 and ϩ40 mV for a 300-ms duration. Voltage steps were applied before and after application of 100 mM glycine in the absence (a) or presence of 100 mMring of quercetin backbone structure (Fig. 1). 8) However, it is unknown whether catechol ring of quercetin is also involved in ligand-gated ion channel activity regulations. In future, further investigations using flavonoids, which are conjugated at carbon-4, will be required to evaluate whether intact catechol ring of flavonoids is also necessary for the regulation of ligand-gated ion channel activity.
In the present study, we found the position of glycosylation to quercetin plays important roles in glycine but not 5-HT 3A receptor channel activity. As shown in Fig. 4 and Table  1 , the IC 50 values of quercetin with monomer or dimer of carbohydrate at carbon-3 were about 2.5-fold higher than that quercetin. Moreover, the IC 50 value of quercetin with trimer of carbohydrate was about 3-fold higher than that quercetin (Fig. 4A) . Thus, glycosylations of quercetin at carbon-3 attenuate quercetin action in quercetin-induced glycine receptor regulations. These results show a possibility that if quercetin glycosides are metabolized into quercetin aglycone, their regulatory effects on glycine receptor channel activity will be recovered as much as quercetin. Interestingly, in case of 5-HT 3A receptor, the degree of quercetin glycosylations did not much affect quercetin-mediated 5-HT 3A receptor channel activity except Rham1, since the IC 50 values of quercetin with monomer or trimer of carbohydrate were not significantly higher than that of quercetin. In addition, it appeared that the maximum inhibition of Rutin on 5-HT 3A receptor channel activity was about 60% compared to quercetin and other quercetin glycosides shown Fig. 4B and Table 1 , even though its IC 50 was similar to others except Rham1. It seems that Rutin might have a low efficiency in the inhibition of 5-HT 3A receptor channel currents compared with quercetin and other quercetin glycosides tested.
From the results of quercetin glycosides' effects on glycine and 5-HT 3A receptor channel activities, we could observe that the possible interaction site(s) of quercetin glycosides with glycine receptor might be different from that of 5-HT 3A receptor, since quercetin glycosides-induced inhibitions of I Gly were non-competitive and voltage-sensitive, whereas quercetin glycosides-induced inhibitions of I 5-HT were competitive and voltage-insensitive manners. It has been known that open channel blockers of ligand-gated ion channels are usually non-competitive and voltage-sensitive, due to the charge that they carry in the transmembrane electrical field of channel pore. [26] [27] [28] This notion is again supported by previous report that site-directed mutations of S267 to S267Y at transmembrane domain 2 (TM2), which is forming channel pore region, almost abolished quercetin-induced inhibition of I Gly .
7) The present and previous results show a possibility that quercetin and its glycosides might play as open channel blockers of glycine receptor.
On the other hand, we also found that quercetin-and its glycosides-induced inhibitions of I 5-HT were competitive and voltage-insensitive manners. It is also known that the competitive inhibitors of 5-HT 3A receptor usually regulate channel activity by inhibiting 5-HT binding to its binding site(s) in N-terminal regions of 5-HT 3A receptor. 29) In competition experiments, we could observe that the presence of quercetin-and its glycosides shifted the concentration of 5-HT in oocytes expressed with 5-HT 3A receptor without significant changes of Hill coefficient (Fig. 5B) . Thus, the competitive modulation of 5-HT 3A receptor channel activity by quercetin and its glycosides shows a possibility that quercetin and its glycosides might have interaction site(s) in N-terminal of 5-HT 3A receptor. In previous report, we have shown that site-directed mutations of N-terminal region of pretransmembrane domain 1 (pre-TM1) such as R246T and R246A but not R246D, R246E and R246K abolished quercetin-induced inhibition of I 5-HT , supporting that quercetin regulates 5-HT 3A receptor channel activities through interaction with N-terminal region of 5-HT 3A receptor. 6) However, identification of the exact interaction sites of quercetin and its glycosides involved in the regulation of glycine or 5-HT 3A receptor channel activity might require further investigations in future.
Interestingly, it is well known that activations of glycine receptor at postsynaptic sites exhibit fast inhibitory postsynaptic potentials, whereas activations of 5-HT 3A at postsynaptic sites exhibit fast excitatory postsynaptic potentials. 22, 23) Therefore, it will be questioned what are the physiological or pharmacological roles of quercetin and its glycosides following the inhibitions of excitatory or inhibitory ligand-gated ion channel activities. Glycine receptors are rich in spinal cord and brain stem, whereas 5-HT 3 receptors exist peripheral nervous systems such as intestines and brain stem area related with emesis in central nervous system. 24, 25) Although we could not clearly answer the roles of quercetin and its glycosides that inhibit both ligand-gated ion channel activities in nervous systems, it seems that quercetin and its glycosides might exert their effects with differential manners in different regions of nervous systems.
In summary, we found that quercetin glycosides inhibit I Gly and I 5-HT in oocytes expressing the human glycine a1 or mouse 5-HT 3A receptors. The glycosylation of quercetin exhibited differential effects on I Gly and I 5-HT , in that quercetin was more potent for the inhibition of I Gly than other quercetin glycosides, whereas quercetin and its glycosides except Rham1 were equally potent for the inhibition of I 5-HT .
